Skip to main content
Premium Trial:

Request an Annual Quote

Two Blades, Monsanto Expand Deal for TAL Code Technologies

NEW YORK (GenomeWeb News) – The Two Blades Foundation and Monsanto today announced an expansion of their agreement to provide Monsanto additional TAL Code technologies.

Details about the expansion of the companies' original deal, including financial terms, were not disclosed. Diana Horvath, chief operating officer for the foundation, said in an e-mail that further details "aren't available at this time."

The TAL Code technology was discovered by researchers at Martin-Luther University in Halle, Germany and is based on novel sequence-specific DNA binding proteins that may be designed for the recognition of almost any sequence of interest. Two Blades has the exclusive rights for commercial use of the technology in plants.

Improvements made by Monsanto to the technology will be granted back to the foundation for its programs in subsistence crops, said Two Blades, which is based in Evanston, Ill., and supports the development of durable disease resistance in crop plants.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.